TAP1 and small cell lung carcinoma: It has been observed that in a SCLC cell line, the presence of a defective allele in TAP1 causes a change of amino acids, which leads to a defective presentation of antigen [47]; in addition, the restoration of TAP1 activity in tumor cells increases the susceptibility to CTL-mediated killing [44].